OTCMKTS:VBIO

Vitality Biophar Stock Insider Trading

Healthcare > Biotechnology

Buy VBIO

*Your capital is at risk

$0.83

+0 (+0%)

At Close: Jun 03, 2026

Vitality Biophar Stock Insider Power

Based on the 53 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 17.24M and sold 1.94M VBIO shares in the last 53 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 53 transactions)	100.00
● Buy	17.24M shares
● Sell	1.94M shares
92% Buy Activity Weak Positive Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
May 21, 2017 Buy	Employee Stock Option (Right to Buy)	Mckilligan Richard CFO, Secretary And Counsel	C-Suite Officer	20 000 Value: $42.0K
Jan 01, 2017 Buy	Employee Stock Option (Right to Buy)	Mckilligan Richard CFO, Secretary And Counsel	C-Suite Officer	20 000 Value: $68.0K
Jan 01, 2015 Buy	Employee Stock Option (Right to Buy)	Mckilligan Richard CFO, Secretary And Counsel	C-Suite Officer	10 000 Value: $27.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VITALITY BIOPHAR

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. wa...

Read Full Profile Here